It is strongly recommended that every time that IntronA is administered to a patient, the name and batch number of the product are recorded in order to maintain a link between the patient and the batch of the product.
IntronA manustamisel patsiendile on väga soovitatav iga kord üles märkida toote nimi ja partii number, et vajadusel oleks võimalik patsienti ja toote partiid seostada.